The regulatory mechanism of NLRP3 inflammasome in the “immune paralytic-overactivation” imbalance in sepsis: the latest progress from molecular signaling to clinical translation - Takeaways - MDSpire

The regulatory mechanism of NLRP3 inflammasome in the “immune paralytic-overactivation” imbalance in sepsis: the latest progress from molecular signaling to clinical translation

  • By

  • Gaosheng Zhou

  • Yifei Chen

  • Dingdeng Wang

  • Yixin Cheng

  • Zhaohui Zhang

  • April 30, 2026

  • 0 min

Share

  • 1

    Sepsis is a critical health issue, affecting 48.9 million people annually and causing approximately 11 million deaths worldwide.

  • 2

    The NLRP3 inflammasome plays a dual role in sepsis, contributing to both pro-inflammatory responses and immunosuppressive effects.

  • 3

    Aberrant activation of the NLRP3 inflammasome is linked to immune dysregulation, leading to organ injury and poor clinical outcomes in sepsis.

  • 4

    Recent studies highlight NLRP3 inhibitors as potential therapeutic targets, showing promise in reducing inflammation and protecting organs.

  • 5

    Understanding the molecular mechanisms of NLRP3 activation may guide future therapeutic strategies to restore immune balance in sepsis.

Original Source(s)

The regulatory mechanism of NLRP3 inflammasome in the “immune paralytic-overactivation” imbalance in sepsis: the latest progress from molecular signaling to clinical translation

  • by Gaosheng Zhou, Yifei Chen, Dingdeng Wang, Yixin Cheng, Zhaohui Zhang

  • April 30, 2026

Related Content

The mechanism of gut microbiota in septic cardiomyopathy based on the bulk transcriptome and Mendelian randomization analysis

Interdisciplinary perspectives on computed tomography in sepsis: survey among medical doctors at a large university medical center

ApoA1/HDL and sepsis-associated vascular endothelial injury: a narrative review